Dachaigh › Luchd-obrach › Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Ferring Pharmaceuticals, Inc. 7 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 6. Tuarastal meadhanach a chaidh a thabhann: $191,048.
A bheil Ferring Pharmaceuticals, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Ferring Pharmaceuticals, Inc. 7 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 27 Lùna 2024. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Med. Science Liaison - Reproductive Med. and Maternal Health | 2 | $175,000 |
| Medical Science Liaison - Reproductive Medicine and Maternal | 1 | — |
| Associate Director, Real World Evidence & HEOR | 1 | $200,000 |
| Associate Director, Clinical Data Management | 1 | $182,097 |
| Principal, Medical Science Liaison | 1 | $200,000 |
| Director, IS Technical Operations | 1 | $219,870 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 4 | $175,000 |
| FY2024 | 3 | $200,000 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Principal, Medical Science Liaison | $200,000 E-3 · Ìre II | Los Angeles, CA | 27 Lùna 2024 | 1 Dùbh 2024 | Dearbhaichte |
| Director, IS Technical Operations | $219,870 | Parsippany, NJ | 1 Lùna 2024 | 6 Dùbh 2024 | Dearbhaichte |
| Associate Director, Clinical Data Management | $182,097 Ìre IV | Parsippany, NJ | 25 Sult 2023 | 23 Màrt 2024 | Dearbhaichte |
| Associate Director, Real World Evidence & HEOR | $200,000 Ìre II | Parsippany, NJ | 2 Lùna 2023 | 14 Lùna 2023 | Dearbhaichte |
| Med. Science Liaison - Reproductive Med. and Maternal Health | $175,000 E-3 · Ìre II | Culver City, CA | 23 Samh 2022 | 1 Gearr 2023 | Dearbhaichte |
| Med. Science Liaison - Reproductive Med. and Maternal Health | $175,000 E-3 · Ìre II | Parsippany, NJ | 29 Sult 2022 | 1 Samh 2022 | Dearbhaichte, an uair sin air a tharraing air ais |
| Medical Science Liaison - Reproductive Medicine and Maternal | $175,000 E-3 · Ìre II | Parsippany, NJ | 29 Sult 2022 | 1 Samh 2022 | Air a tharraing air ais |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).